Jazz Pharmaceuticals (JAZZ -7%) receives an FDA warning letter describing multiple safety...

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor

Jazz Pharmaceuticals (JAZZ -7%) receives an FDA warning letter describing multiple safety violations, including "failure to develop adequate written procedures for the surveillance, receipt, evaluation, and reporting of postmarketing adverse drug experiences to FDA."